Ninth Central European Life Science Investment Conference
Hotel Stary, Krakow, 16-18 October 2019

This year’s top level theme:
“Do Darwinian principles apply to the biotech industry?”

Agenda correct on
7 October 2019

16 October 2019 
18.00 - 20.00 Registration open

Pre-conference Drinks Reception at the Hotel Stary
Wine from the Fantastic View and Jagiellonian University vineyards (Poland)

17 October 2019

8.00 Registration Open

Opening session: Darwinian forces in the Business of Biotechnology


Opening Remarks
Roland Kozlowski, LSBC(London), United Kingdom


Talk: Forces for change, DaDa, Bowie and Biotechnology 
Anthony Sedgwick, Thought Disruptor, United Kingdom

10.00 Talk: Is Change Management a Darwinian process? 
Andrew Skowronski, A&C Associates, Singapore
10:45 Coffee & Networking
11:30 Technology Transfer
11.30 Panel: Compare and contrast technology transfer in developing and mature markets

Chair:  Dariusz Wiatr, Business Angel, USA / Poland

Leszek Grabarczyk, Audere Group, Poland
Mikołaj Gurdała, EIT Health InnoStars, Hungary
David Vita, Redbreek Fund, Israel
Michał Gwizda, Crido, Poland


Company Presentations

Bioceltix Sp. z o.o.  Poland
Simplicardiac sp. z o.o., Poland
HiProMine S.A., Poland

13.00 - 14.00 Networking lunch
14.00 Session: Financing
Chair: Stefan Ogrodziński
14.00 Panel: The funding gap: “kiss of death or natural selection?”

Stefan Ogrodziński, OncoTherics Limited, United Kingdom

Mikołaj Gurdała, EIT Health InnoStars, Hungary

Ronald Landes, Von Baer Wolff, USA
Pawel Wielgus, Kvarko, Poland
Robert Watson, Gyrus Capital, Switzerland
Sanjeev Choudhary, Medinice, Poland

14.45 Panel: Listing - a fund raising or exit event comparing developing and mature markets

Chair: Tania Fernandez, Dreamcatcher Ventures, USA

Paweł Przewięźlikowski, Ryvu Therapeutics S.A., Poland
John Bason, PFR, Poland
Artur Chabowski, Lipid Systems, Poland
Marcin Szuba, Lartiq, Poland
Steven Powell, eTheRNA, United Kingdom

15.30 - 16.15 TEA & Networking
16.15 - 17.00 Session: Management Issues

Panel:  Will the polish biotech and associated investment industry succeed without experienced management?

Chair: Matthew Tabeau, Proteon, Poland

Karolina Jarosińska, ExecMind, Poland
Paul Edwards, Horton International, United Kingdom
John Borg, EMA, Malta
Mariusz Olejniczak, WPD Pharmaceuticals sp. z o.o.
Tracy Weightman, Bridge Valley Ventures, United Kingdom

17.00 Open discussion from the floor and conference close for the day
19:30 Networking drinks, Wine Tasting, Conference Dinner & Live Music: Restaurant Pod Różą
Wine from the Fantastic View and Jagiellonian University Vineyards (Poland)

18 October 2018

9.30 Session: Company Presentations

Cellese Limited, United Kingdom
Captor Therapeutics S.A., Poland
DEBN Sp. z o.o., Poland
Medinice SA, Poland
OncoTherics Limited., United Kingdom
Orion Biotechnology Polska Sp. z o.o., Poland
Pharmacann Sp zo.o. Poland
Wheelstair Sp z o.o., Poland

11.00 Coffee & Networking
12.00 Preparing for the Future

Talk: Low capital intensity biotech: a better way forward for the CE region?

Chair: Mark Treherne, Cellese, United Kingdom

Marek Borzestowski, Giza Polish Ventures, Poland
Dominik Ziętkowski, Blirt, Poland
Fillip Jeleń, Captor Therapeutics S.A., Poland
Francois Mereau, Mereau Partners, France
Artur Chabowski, Lipid Systems, Poland


Brainstorm panel / Open session: “predicting the future”
Panelists: Five participants chosen from conference attendees over dinner who have something bold they would like to raise! Themes taken from earlier panels and talks.

Chair: Roland Kozlowski, LSBC (London) Limited, UK


Summing up and Conference Close
Roland Kozlowski